670 results on '"Lopez, Angel F"'
Search Results
2. Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade
3. IgE receptor of mast cells signals mediator release and inflammation via adaptor protein 14-3-3ζ
4. Cytokine Receptors and Their Ligands
5. Translating the biology of β common receptor-engaging cytokines into clinical medicine
6. TLR7 gain-of-function genetic variation causes human lupus
7. Targeting the Human βc Receptor Inhibits Contact Dermatitis in a Transgenic Mouse Model
8. Understanding mast cell heterogeneity at single cell resolution
9. Messing with βc: A unique receptor with many goals
10. CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
11. Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody
12. 14-3-3ζ mediates an alternative, non-thermogenic mechanism in male mice to reduce heat loss and improve cold tolerance
13. Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis
14. Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models
15. Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
16. Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases
17. Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract
18. 14-3-3ε and ζ Regulate Neurogenesis and Differentiation of Neuronal Progenitor Cells in the Developing Brain
19. Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade
20. Role of salt bridges in the dimer interface of 14-3-3ζ in dimer dynamics, N-terminal α-helical order, and molecular chaperone activity
21. Supplementary File 2 from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
22. Data from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
23. Supplementary Figure S1 from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
24. Supplementary Movie from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
25. Supplementary File 1 from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
26. Figure S7 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
27. Supplementary Table S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
28. Data from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
29. Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
30. High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression
31. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia
32. Regulation of Eosinophil Function by P-Selectin
33. Structural Basis for the GM-CSF- and IL-3-Mediated Stimulation of Eosinophil Production and Function in Humans
34. Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
35. The IgE receptor of mast cells signals mediator release and inflammation via the adaptor protein 14-3-3ζ
36. Apoptosis of Hemopoietic Cells by the Human Granulocyte-Macrophage Colony-Stimulating Factor Mutant E21R
37. Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling
38. Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
39. A Negative Regulatory Mechanism Involving 14-3-3ζ Limits Signaling Downstream of ROCK to Regulate Tissue Stiffness in Epidermal Homeostasis
40. The βc receptor family – Structural insights and their functional implications
41. Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties
42. Translating the biology of β common receptor-engaging cytokines into clinical medicine
43. Mechanisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation
44. Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells
45. EPO does not promote interaction between the erythropoietin and beta-common receptors
46. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis
47. Potential for Hematopoietic Growth Factor Antagonists in Oncology
48. Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription
49. Signalling by the βc family of cytokines
50. Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.